Companies are employing AI to respond to the Covid-19 pandemic in a number of different ways, including diagnosing Covid-19 cases, identifying which patients would be at highest risk and discovering potential treatments. But not all of these approaches have been validated, experts warned.
Numerous emerging companies aim to fix America's broken healthcare system. How can we differentiate between solving the issue and contributing to the system's existing fragmentation?
Munck Wilson Mandala Partner Greg Howison shared his perspective on some of the legal ramifications around AI, IP, connected devices and the data they generate, in response to emailed questions.
GE Ventures led the $10.8 million Series A investment, joined by Greycroft Partners, Flare Capital Partners and Manatt Ventures.